Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia

New England Journal of Medicine

Volumn 350, Issue 5, 2004, Pages 451-458

  Gibot, Sébastien ^a   Cravoisy, Aurélie ^a   Levy, Bruno ^a   Bene, Marie Christine ^b   Faure, Gilbert ^b   Bollaert, Pierre Edouard ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; FEMALE; HUMAN; IMMUNOBLOTTING; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PHAGOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; LUNG DISEASES, FUNGAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYELOID CELLS; PNEUMONIA; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; RESPIRATION, ARTIFICIAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 1642499233     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa031544     Document Type: Article

References (28)

1. Wunderink RG. Mortality and the diagnosis of ventilator-associated pneumonia: a new direction. Am J Respir Crit Care Med 1998;157:349-50.
2. Baker AM, Meredith JW, Haponik EF. Pneumonia in intubated trauma patients: microbiology and outcomes. Am J Respir Crit Care Med 1996;153:343-9.
3. Fagon JY, Chastre J, Hance AJ, Domart Y, Trouillet JL, Gibert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993;103:547-53.
4. Helling TS, Van Way C III, Krantz S, Bertram K, Stewart A. The value of clinical judgment in the diagnosis of nosocomial pneumonja. Am J Surg 1996;171:570-5.
5. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
6. Meduri GU, Wunderink RG, Leeper KV, Beals DH. Management of bacterial pneumonia in ventilated patients: protected bronchoalveolar lavage as a diagnostic tool. Chest 1992;101:500-8.
7. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 2000;132:621-30.
8. Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995;152:1982-91.
9. Campbell GD Jr. Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 2000;117:Suppl 2:207S-211S.
10. Duflo F, Debon R, Monneret G, Bienvenu J, Chassard D, Allaouchiche B. Alveolar and serum procalcitonin: diagnosticand prognostic value in ventilator-associated pneumonia. Anesthesiology 2002;96:74-9.
11. Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycld ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect 2002;8:93-100.
12. Fukushima R, Alexander JW, Gianotti L, Ogle CK. Isolated pulmonary infection acts as a source of systemic tumor necrosis factor. Crit Care Med 1994;22:114-20.
13. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995;108:1303-14.
14. Monton C, Torres A, El-Ebiary, Filella X, Xaubet A, de la Bellacasa JP. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999;27:1745-53.
15. WU CL, Lee LY, Chang KM, et al. Bronchoalveolar interleukin-1β: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Crit Care Med 2003;31:812-7.
16. Bonten MJ, Froon AH, Gaillard CA, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1105-13.
17. Bouchon A, Dietrich J, Colonna M. Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164:4991-5.
18. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410:1103-7.
19. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic"blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-9.
20. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med 1982;110:847-64.
21. Le Gall JP, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. [Erratum, JAMA 1994;271:1321.]
22. Le Gall JP, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63. [Erratum, JAMA 1994;271:1321.]
23. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707-10.
24. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
25. Amyes SG. Strategies and options for minimizing resistance emergence in pulmonary infections. Chest 1998;113:Suppl:228S-232S.
26. Birmingham MC, Hassett JM, Schentag JJ, Paladino JA. Assessing antibacterial pharmacoeconomics in the intensive care unit. Pharmacoeconomics 1997;12:637-47
27. Nathan C, Ding A. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nat Med 2001;7:530-2.
28. Cohen J. TREM-1 in sepsis. Lancet 2001;358:776-8.